Recombinant tissue plasminogen activator attenuates basal lamina antigen loss after experimental focal cerebral ischemia

Neurological Research

Volumn 27, Issue 2, 2005, Pages 212-217

  Grobholz, Katharina ^a   Burggraf, Dorothe ^a   Helge Martens, K ^a   Wunderlich, Nathalie ^a   Pichler, Matthias ^a   Hamann, F Gerhard ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Basal lamina; Focal cerebral ischemia; Microvasculature; Thrombolysis

Indexed keywords

ALTEPLASE; COLLAGEN TYPE 4; MICROTUBULE ASSOCIATED PROTEIN 2; PROTEIN ANTIBODY; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BASAL GANGLION; BLEEDING; BRAIN CORTEX; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; CAPILLARY BASEMENT MEMBRANE; CONTROLLED STUDY; DENSITY; DOSE RESPONSE; DRUG EFFECT; EXPERIMENTAL MODEL; IMAGE RECONSTRUCTION; IMMUNOHISTOCHEMISTRY; LOW DRUG DOSE; MALE; MICROVASCULATURE; NEUROPROTECTION; NONHUMAN; RAT; REPERFUSION INJURY; STROKE; STRUCTURE ANALYSIS; THREE DIMENSIONAL IMAGING; TISSUE STRUCTURE; VASCULAR ENDOTHELIUM; VASCULAR PATENCY;

ANALYSIS OF VARIANCE; ANIMALS; BRAIN; BRAIN ISCHEMIA; COLLAGEN TYPE IV; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FIBRINOLYTIC AGENTS; IMMUNOHISTOCHEMISTRY; MALE; MICROCIRCULATION; MICROSCOPY, VIDEO; MICROTUBULE-ASSOCIATED PROTEINS; RATS; RATS, WISTAR; RECOMBINANT PROTEINS; REPERFUSION INJURY; TIME FACTORS; TISSUE PLASMINOGEN ACTIVATOR;

EID: 15244351295     PISSN: 01616412     EISSN: None     Source Type: Journal    
DOI: 10.1179/016164105X35576     Document Type: Article

References (25)

1. Dirnagl U, Iadecola C, Moskowitz MA. Pathobiology of ischemic stroke: An integrated view. Trends Neurosci 1999; 22: 391-397
2. Hamann GF, Okada Y, Fitridge R, et al. Microvascular basal lamina antigens disappear during cerebral ischemia and reperfusion. Stroke 1995; 26: 2120-2126
3. Hamann GF, Okada Y, del Zoppo GJ. Hemorrhagic transformation and microvascular integrity during focal cerebral ischemia/ reperfusion. J Cereb Blood Flow Metab 1996; 16: 1373-1378
4. Yurchenco PD, Schittny JC. Molecular architecture of basement membranes. FASEB J 1990; 4: 1577-1590
5. Hamann GF, Liebetrau M, Martens HK, et al. Microvascular basal lamina injury following experimental focal cerebral ischemia and reperfusion. J Cereb Blood Flow Metab 2002; 22: 526-533
6. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue-plasminogen activator for acute ischemic stroke. N Engl J Med 1995; 333: 1581-1587
7. Longa EZ, Weinstein PR, Carlson S, et al. Reversible middle cerebral artery occlusion without craniotomy in rats. Stroke 1989; 20: 84-91
8. Paxinos G and Watson C. The Rat Brain, 4th edn, San Diego: Academic Press, 1998
9. Kloss CU, Thomassen N, Fesl G, et al. Tissue-saving infarct volumetry using histochemistry validated by MRI in rat focal ischemia. Neurol Res 2002; 24: 713-718
10. Hacke W, Kaste M, Fieschi C, et al. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. JAMA 1995; 274: 1017-1025
11. del Zoppo GJ, Hallenbeck JM. Advances in the vascular pathophysiology of ischemic stroke. Thromb Res 2000; 98: 73-81
12. Betz AL, Ennis SR, Schielke GP. Blood-brain barrier sodium transport limits development of brain edema during partial ischemia in gerbils. Stroke 1989; 20: 1253-1259
13. Pfefferkorn T, Staufer B, Liebetrau M, et al. Plasminogen activation in focal cerebral ischemia and reperfusion. J Cereb Blood Flow Metab 2000; 20: 337-342
14. Lijnen HR, Van Hoef B, Lupu F, et al. Function of the plasminogen/ plasmin and matrix metalloproteinase systems after vascular injury in mice with targeted inactivation of fibrinolytic system genes. Arterioscler Thromb Vasc Biol 1998; 18: 1035-1045
15. Kittaka M, Wang L, Sun N, et al. Brain capillary tissue plasminogen activator in a diabetes stroke model. Stroke 1996; 27: 712-719
16. Burggraf D, Martens HK, Jäger G, et al. Recombinant human tissue plasminogen activator protects the basal lamina in experimental focal cerebral ischemia. Thromb Haemost 2003; 89: 1072-1080
17. Klein GM, Li H, Sun P, et al. Tissue plasminogen activator does not increase neuronal damage in rat models of global and focal ischemia. Neurology 1999; 52: 1381-1384
18. Kilic E, Hermann DM, Hossmann KA. Recombinant tissue plasminogen activator reduces infarct size after reversible thread occlusion of middle cerebral artery in mice. Neuro Rep 1999; 10: 107-111
19. Pittman RN, Di Benedetto AJ. PC12 cells overexpressing tissue plasminogen activator regenerate neurites to a greater extent and migrate faster than control cells in complex extracellular matrix. J Neurochem 1995; 64: 566-575
20. Tsirka SE, Rogove AD, Bugge TH, et al. An extracellular proteolytic cascade promotes neuronal degeneration in the mouse hippocampus. J Neurosci 1997; 17: 543-552
21. Nagai N, Yamamoto S, Tsuboi T, et al. Tissue-type plasminogen activator is involved in the process of neuronal death induced by oxygen-glucose deprivation in culture. J Cereb Blood Flow Metab 2001; 21: 631-634
22. Wang YF, Tsirka SE, Strickland S, et al. Tissue plasminogen activator (tPA) increases neuronal damage after focal cerebral ischemia in wild-type and tPA-deficient mice. Nat Med 1998; 4: 228-231
23. Lipton SA, Rosenberg PA. Mechanisms of disease: Excitatory amino acids as a final common pathway for neurologic disorders. N Engl J Med 1994: 330; 613-622
24. Tsirka SE, Gualandris A., Amaral DG, et al. Excitotoxin-induced neuronal degeneration and seizure are mediated by tissue plasminogen activator. Nature 1995; 377: 340-344
25. Karges HE, Funk KA, Ronneberger H. Activity of coagulation and fibrinolysis parameters in animals. Arzneimittelforschung (Germany) 1994; 44: 793-797